ISOVUE

This brand name is authorized in Canada, United States

Active ingredients

The drug ISOVUE contains one active pharmaceutical ingredient (API):

1 Iopamidol UNII JR13W81H44 - IOPAMIDOL

Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media. Read about Iopamidol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ISOVUE 200/250/300/370 Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
V08AB04	Iopamidol	V Various → V08 Contrast media → V08A X-ray contrast media, iodinated → V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
Discover more medicines within V08AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02229013, 02229021, 02229048, 02242121, 02242122
Country: US	FDA, National Drug Code	Identifier(s): 0270-1314, 0270-1315, 0270-1316, 0270-1317, 0270-1411, 0270-1412